主要组织相容性复合体I类分子Mamu - A*01的表达与猿猴免疫缺陷病毒SIVmac239复制的控制相关。
Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication.
作者信息
Mothé Bianca R, Weinfurter Jason, Wang Chenxi, Rehrauer William, Wilson Nancy, Allen Todd M, Allison David B, Watkins David I
机构信息
Wisconsin Regional Primate Research Center, University of Wisconsin, 1220 Capitol Court, Madison, WI 53715-1299, USA.
出版信息
J Virol. 2003 Feb;77(4):2736-40. doi: 10.1128/jvi.77.4.2736-2740.2003.
Abstract
Several HLA alleles are associated with attenuated human immunodeficiency virus disease progression. We explored the relationship between the expression of particular major histocompatibility complex (MHC) class I alleles and viremia in simian immunodeficiency virus SIV(mac)239-infected macaques. Of the common MHC class I alleles, animals that expressed Mamu-A*01 exhibited the best control of viral replication.
摘要
几种人类白细胞抗原（HLA）等位基因与人类免疫缺陷病毒疾病进展减缓相关。我们探讨了特定主要组织相容性复合体（MHC）I类等位基因的表达与感染猿猴免疫缺陷病毒SIV（mac）239的猕猴病毒血症之间的关系。在常见的MHC I类等位基因中，表达Mamu - A*01的动物对病毒复制的控制最佳。
相似文献
1
Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication.
J Virol. 2003 Feb;77(4):2736-40. doi: 10.1128/jvi.77.4.2736-2740.2003.
2
Rhesus Macaques Vaccinated with , , and Manifest Early Control of SIVmac239 Replication.
J Virol. 2018 Jul 31;92(16). doi: 10.1128/JVI.00690-18. Print 2018 Aug 15.
3
Mamu-B*08-positive macaques control simian immunodeficiency virus replication.
J Virol. 2007 Aug;81(16):8827-32. doi: 10.1128/JVI.00895-07. Epub 2007 May 30.
4
The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication.
J Virol. 2006 May;80(10):5074-7. doi: 10.1128/JVI.80.10.5074-5077.2006.
5
Infection with "escaped" virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu-B*08-positive macaques.
J Virol. 2009 Nov;83(22):11514-27. doi: 10.1128/JVI.01298-09. Epub 2009 Sep 2.
6
Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication.
J Virol. 2008 Feb;82(4):1723-38. doi: 10.1128/JVI.02084-07. Epub 2007 Dec 5.
7
Control of simian immunodeficiency virus SIVmac239 is not predicted by inheritance of Mamu-B*17-containing haplotypes.
J Virol. 2007 Jan;81(1):406-10. doi: 10.1128/JVI.01636-06. Epub 2006 Nov 1.
8
Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques.
J Virol. 2008 Jun;82(11):5245-54. doi: 10.1128/JVI.00292-08. Epub 2008 Apr 2.
9
MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys.
J Immunol. 2002 Sep 15;169(6):3438-46. doi: 10.4049/jimmunol.169.6.3438.
10
The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers.
J Virol. 2008 Jan;82(2):859-70. doi: 10.1128/JVI.01816-07. Epub 2007 Nov 7.
引用本文的文献
1
Immune Alterations and Viral Reservoir Atlas in SIV-Infected Chinese Rhesus Macaques.
Infect Dis Rep. 2025 Feb 6;17(1):12. doi: 10.3390/idr17010012.
2
Neonatal immunity associated with heterologous HIV-1 neutralizing antibody induction in SHIV-infected Rhesus Macaques.
Nat Commun. 2024 Nov 27;15(1):10302. doi: 10.1038/s41467-024-54753-6.
3
Elevated Inflammation Associated with Markers of Neutrophil Function and Gastrointestinal Disruption in Pilot Study of Co-Infection of ART-Treated SIVmac239+ Rhesus Macaques.
Viruses. 2024 Jun 27;16(7):1036. doi: 10.3390/v16071036.
4
Immunotoxin-mediated depletion of Gag-specific CD8+ T cells undermines natural control of SIV.
JCI Insight. 2024 Jun 17;9(14):e174168. doi: 10.1172/jci.insight.174168.
5
Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques.
Science. 2024 Mar 8;383(6687):1104-1111. doi: 10.1126/science.adf7966. Epub 2024 Feb 29.
6
The Impact and Effects of Host Immunogenetics on Infectious Disease Studies Using Non-Human Primates in Biomedical Research.
Microorganisms. 2024 Jan 12;12(1):155. doi: 10.3390/microorganisms12010155.
7
Host immunity associated with spontaneous suppression of viremia in therapy-naïve young rhesus macaques following neonatal SHIV infection.
J Virol. 2023 Nov 30;97(11):e0109423. doi: 10.1128/jvi.01094-23. Epub 2023 Oct 24.
8
Neonatal SHIV infection in rhesus macaques elicited heterologous HIV-1-neutralizing antibodies.
Cell Rep. 2023 Mar 28;42(3):112255. doi: 10.1016/j.celrep.2023.112255. Epub 2023 Mar 14.
9
Long-read assembly of major histocompatibility complex and killer cell immunoglobulin-like receptor genome regions in cynomolgus macaque.
Biol Direct. 2022 Nov 29;17(1):36. doi: 10.1186/s13062-022-00350-w.
10
V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques.
Front Immunol. 2022 Jul 22;13:914969. doi: 10.3389/fimmu.2022.914969. eCollection 2022.
本文引用的文献
1
Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.
Nat Med. 2002 May;8(5):493-9. doi: 10.1038/nm0502-493.
2
Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection.
J Virol. 2002 Jan;76(2):875-84. doi: 10.1128/jvi.76.2.875-884.2002.
3
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
J Virol. 2002 Jan;76(1):292-302. doi: 10.1128/jvi.76.1.292-302.2002.
4
Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection.
J Exp Med. 2001 Jan 15;193(2):181-94. doi: 10.1084/jem.193.2.181.
5
CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.
J Virol. 2001 Jan;75(2):738-49. doi: 10.1128/JVI.75.2.738-749.2001.
6
Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.
Nature. 2000 Sep 21;407(6802):386-90. doi: 10.1038/35030124.
7
Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape.
Stem Cells. 2000;18(4):230-44. doi: 10.1634/stemcells.18-4-230.
8
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.
Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2709-14. doi: 10.1073/pnas.050567397.
9
Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.
Nat Med. 1999 Nov;5(11):1270-6. doi: 10.1038/15224.
10
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.
Science. 1999 Mar 12;283(5408):1748-52. doi: 10.1126/science.283.5408.1748.
Zotero 插件